TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival

Por Liu, Weiguang, Zhang, Lei, Jin, Zining, Zhao, Min, Li, Zhan, Chen, Guanglei, Sun, Lisha, Chen, Bo
Publicado no Oncotarget (2017)

Expression and clinicopathological significance of FSIP1 in breast cancer

Por Zhang, Hao, Luo, Minna, Jin, Zining, Wang, Dan, Sun, Ming, Zhao, Xinhan, Zhao, Zuowei, Lei, Haixin, Li, Man, Liu, Caigang
Publicado no Oncotarget (2015)

Clinical significance of MSKCC nomogram on guiding the application of touch imprint cytology and frozen section in intraoperative assessment of breast sentinel lymph nodes

Por Sun, Lisha, Chen, Guanglei, Zhou, Yizhen, Zhang, Lei, Jin, Zining, Liu, Weiguang, Wu, Guangping, Jin, Feng, Li, Kai, Chen, Bo
Publicado no Oncotarget (2017)

Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses

Por Jin, Zining, Xu, Lu, Zhang, Lei, Zhao, Min, Li, Dongbao, Ye, Lijun, Ma, Ying, Ren, Siyu, Yu, Hailan, Wang, Danyu, Liang, Chunyan, Chen, Bo
Publicado no Am J Transl Res (2018)

Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy

Por Jin, Zining, Wang, Wenqian, Jiang, Nan, Zhang, Lei, Li, Yiming, Xu, Xiaoyin, Cai, Shouliang, Wei, Liang, Liu, Xuhong, Chen, Guanglei, Zhou, Yizhen, Liu, Cheng, Li, Zhan, Jin, Feng, Chen, Bo
Publicado no PLoS One (2015)